View in EDS HTML Full Text PDF Full Text

B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape.

Saved in:
Bibliographic Details
Title: B7-H3 nanobody-based CAR T cells control multiple myeloma growth, while dual BCMA/B7-H3 CAR T cells overcome antigen escape.
Authors: Van der Vreken, Arne1 (AUTHOR), Meeus, Fien1 (AUTHOR), Tu, Chenggong1 (AUTHOR), van den Broecke, Lauren1 (AUTHOR), Raimondi, Vincenzo2 (AUTHOR), Vescovini, Rosanna2 (AUTHOR), Hanssens, Heleen1 (AUTHOR), Watté, Fenja1 (AUTHOR), Autaers, Dorien1 (AUTHOR), Aragon, Marta Marco1 (AUTHOR), Billiau, Janne3 (AUTHOR), De Veirman, Kim1 (AUTHOR), Vanderkerken, Karin1 (AUTHOR), De Vlaeminck, Yannick1 (AUTHOR), Franceschini, Lorenzo1 (AUTHOR), Lee, Holly4 (AUTHOR), Neri, Paola4 (AUTHOR), De Bruyne, Elke1 (AUTHOR), Storti, Paola2 (AUTHOR), Giuliani, Nicola2 (AUTHOR)
Source: Journal of Hematology & Oncology. 11/14/2025, Vol. 18 Issue 1, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17568722
DOI:10.1186/s13045-025-01756-5